Republican challenger Dave McCormick said bad economic policy from the Biden administration deserves all the blame. “Corporations were engaged in price gouging, taking advantage of the pandemic and ...
The biosimilar market continued to grow, with 57 approved biosimilars and 17 reference product biologics as of June 2024. Biosimilars that have seen the fastest uptake have been in oncology, ...